Clinical Trials Browser

Metastatic Castration-Resistant Prostate Cancer (mCRPC) × Genitourinary × 90 days × Clear all

NCT05806814 2026-03-05

OU-SCC-EXCITE

Phase 1 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT05670106 2026-02-13

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Phase 2 Active not recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)